Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection-Reference-Cited by-同舟云学术

Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection

Published:2023-09-07 Issue:10 Volume:16 Page:939-957
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Osuala Emmanuella Chinonso¹²,Naidoo Anushka¹,Dooley Kelly E³,Naidoo Kogieleum¹⁴,Perumal Rubeshan¹⁴

Affiliation:

1. Center for the AIDS Program of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa

2. Discipline of Pharmacology, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

3. Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

4. MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2251387

Reference114 articles.

1. UNAIDS. HIV/AIDS. Fact sheet—latest global and regional statistics on the status of the HIV epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2022.

2. Defeating AIDS—advancing global health

3. A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population

4. The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy

5. Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14